These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1482222)

  • 41. Clonidine transdermal patches for use in outpatient opiate withdrawal.
    Spencer L; Gregory M
    J Subst Abuse Treat; 1989; 6(2):113-7. PubMed ID: 2664204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of sucrose on acute tobacco withdrawal in women.
    Helmers KF; Young SN
    Psychopharmacology (Berl); 1998 Oct; 139(3):217-21. PubMed ID: 9784076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of clonidine on cigarette cessation and in the alleviation of withdrawal symptoms.
    Hao W; Young D
    Br J Addict; 1988 Oct; 83(10):1221-6. PubMed ID: 3056540
    [No Abstract]   [Full Text] [Related]  

  • 44. Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension.
    Kolloch RE; Mehlburger L; Schumacher H; Göbel BO
    Clin Auton Res; 1993 Dec; 3(6):373-8. PubMed ID: 8193524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transdermal clonidine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Langley MS; Heel RC
    Drugs; 1988 Feb; 35(2):123-42. PubMed ID: 3281820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comment: oral clonidine in nicotine withdrawal.
    Day RG
    DICP; 1989 Dec; 23(12):1035-6. PubMed ID: 2603449
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment of menopausal hot flashes with transdermal administration of clonidine.
    Nagamani M; Kelver ME; Smith ER
    Am J Obstet Gynecol; 1987 Mar; 156(3):561-5. PubMed ID: 3826200
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Symptoms of clonidine withdrawal after 17 days.
    Frolich JC
    N Engl J Med; 1976 Nov; 295(22):1261-2. PubMed ID: 980045
    [No Abstract]   [Full Text] [Related]  

  • 49. Transdermal clonidine.
    Noerr B
    Neonatal Netw; 2000 Mar; 19(2):67-9. PubMed ID: 11949002
    [No Abstract]   [Full Text] [Related]  

  • 50. Transdermal clonidine: therapeutic considerations.
    Sica DA; Grubbs R
    J Clin Hypertens (Greenwich); 2005 Sep; 7(9):558-62. PubMed ID: 16227779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of clonidine in nicotine withdrawal.
    Sees KL; Clark HW
    J Psychoactive Drugs; 1988; 20(3):263-8. PubMed ID: 3069985
    [No Abstract]   [Full Text] [Related]  

  • 52. Letter: Clonidine (Catapres) overshoot.
    Bailey RR
    N Z Med J; 1975 Mar; 81(535):268-9. PubMed ID: 1055331
    [No Abstract]   [Full Text] [Related]  

  • 53. Clonidine (Catapres) for hypertension.
    Med Lett Drugs Ther; 1975 May; 17(11):45-6. PubMed ID: 1128440
    [No Abstract]   [Full Text] [Related]  

  • 54. In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children.
    Ke GM; Wang L; Xue HY; Lu WL; Zhang X; Zhang Q; Guo HY
    Biol Pharm Bull; 2005 Feb; 28(2):305-10. PubMed ID: 15684489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of clonidine in treatment of alcohol withdrawal state.
    Wilkins AJ; Jenkins WJ; Steiner JA
    Psychopharmacology (Berl); 1983; 81(1):78-80. PubMed ID: 6415735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the pharmacokinetics, pharmacodynamics, and safety of oral (Catapres) and transdermal (M-5041T) clonidine in healthy subjects.
    Fujimura A; Ebihara A; Ohashi K; Shiga T; Kumagai Y; Nakashima H; Kotegawa T
    J Clin Pharmacol; 1994 Mar; 34(3):260-5. PubMed ID: 8021335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Haight-Ashbury Free Clinics' drug detoxification protocols--Part 1: Opioids.
    Galloway G; Hayner G
    J Psychoactive Drugs; 1993; 25(2):157-8. PubMed ID: 8377084
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of post-orchiectomy hot flashes with transdermal administration of clonidine.
    Parra RO; Gregory JG
    J Urol; 1990 Apr; 143(4):753-4. PubMed ID: 2313799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Withdrawal syndrome upon cessation of chronic clonidine treatment in rats.
    Dix RK; Johnson EM
    Eur J Pharmacol; 1977 Jul; 44(2):153-9. PubMed ID: 18357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transdermal clonidine in the prophylaxis of episodic cluster headache: an open study.
    Leone M; Attanasio A; Grazzi L; Libro G; D'Amico D; Moschiano F; Bussone G
    Headache; 1997 Oct; 37(9):559-60. PubMed ID: 9385753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.